COMMUNIQUÉS West-GlobeNewswire

-
Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Completion of the Merger with OncoMed Pharmaceuticals, Inc.
23/04/2019 -
Reduction of GN Store Nord’s share capital
23/04/2019 -
Nova Leap Health Corp. Completes Purchase of Home Care Business in Eastern Canada
23/04/2019 -
Demant A/S: Capital reduction as well as total number of voting rights and capital
23/04/2019 -
AXIM® Biotechnologies, Inc. Nutraceutical Division Receives Purchase Order for 50,000 Boxes of the Company’s Proprietary CBD-Based Chewing Gum
23/04/2019 -
Predictive Technology Group Integrates Sales and Marketing Team from FlagshipHealth Group
23/04/2019 -
Ventura Cannabis Releases Results of AGM; Announces Updated Plan to Become a California Cannabis Branded Product Company
23/04/2019 -
CohBar Announces Key Opinion Leader Conference Call and Webcast
23/04/2019 -
Radius Health to Announce First Quarter 2019 Financial Results, Host Conference Call and Live Webcast on Wednesday, May 8, 2019
23/04/2019 -
LIDDS: Updated Research Report from Redeye
23/04/2019 -
Guardant Health Appoints Dr. Bahija Jallal to its Board of Directors
23/04/2019 -
Yield10 Bioscience Announces Notice of Allowance for U.S. Patent Covering Crop Yield Trait C3003
23/04/2019 -
ARCA biopharma Announces Steering Committee of Leading International Cardiology and Electrophysiology Experts for PRECISION-AF Phase 3 Clinical Trial
23/04/2019 -
Pascal Biosciences Provides Corporate Update for First Quarter of 2019
23/04/2019 -
AIT Therapeutics to Demonstrate NO Generator and Delivery System at Pediatric Academic Societies Meeting in Baltimore, MD on April 27-30
23/04/2019 -
Akari Therapeutics Announces Positive Initial Phase II Clinical Data in Orphan Skin Disease Bullous Pemphigoid
23/04/2019 -
ExCellThera’s lead technology, ECT-001, receives FDA Regenerative Medicine Advanced Therapy (RMAT) designation
23/04/2019 -
Japan Cell Therapy Transaction Yields $3MM
23/04/2019 -
Entasis Therapeutics Strengthens Leadership Team with Appointment of Eric Kimble as Chief Commercial Officer
23/04/2019
Pages